Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17827480 | 0.92 | ALOX5 (0.33) | ALOX5 | |
| SCHEMBL17805136 | 0.90 | ALOX5 (0.31) | ALOX5 | |
| SCHEMBL17855611 | 0.87 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL23867388 | 0.86 | RAB9A (0.34) | ALOX5NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL17827447 | 0.86 | — | — | |
| SCHEMBL17855922 | 0.85 | ALOX5 (0.31) | ALOX5RAB9A | |
| SCHEMBL17126347 | 0.85 | ALOX5 (0.35) | ALOX5NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23180197 | 0.84 | NPC1 (0.33) | ALOX5NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23180746 | 0.84 | NPC1 (0.33) | ALOX5NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL24024334 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9929355-B2 | Amine compound and organic electroluminescent device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-27 | — | — | US | disclosed |
| US-9929355-B2 | Amine compound and organic electroluminescent device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-27 | — | — | US | disclosed |
| US-20160172593-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
| US-20160172593-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160172593-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | AOC2, SAT1, ODC1 | ALOX5 1438/4885NPC1 2225/4885CYP1A2 212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.